US 10550129
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted A61PA61P25/00A61P25/14
Quick answer
US patent 10550129 (1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18